ATE491706T1 - Heterocyclische antivirale verbindungen - Google Patents

Heterocyclische antivirale verbindungen

Info

Publication number
ATE491706T1
ATE491706T1 AT07704418T AT07704418T ATE491706T1 AT E491706 T1 ATE491706 T1 AT E491706T1 AT 07704418 T AT07704418 T AT 07704418T AT 07704418 T AT07704418 T AT 07704418T AT E491706 T1 ATE491706 T1 AT E491706T1
Authority
AT
Austria
Prior art keywords
antiviral compounds
heterocyclic antiviral
heterocyclic
compounds
hepatitis
Prior art date
Application number
AT07704418T
Other languages
English (en)
Inventor
Jay Bradford Fell
Peter Mohr
Peter J Stengel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE491706T1 publication Critical patent/ATE491706T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07704418T 2006-02-17 2007-02-07 Heterocyclische antivirale verbindungen ATE491706T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77441906P 2006-02-17 2006-02-17
PCT/EP2007/051162 WO2007093541A1 (en) 2006-02-17 2007-02-07 Heterocyclic antiviral compounds

Publications (1)

Publication Number Publication Date
ATE491706T1 true ATE491706T1 (de) 2011-01-15

Family

ID=38115973

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07704418T ATE491706T1 (de) 2006-02-17 2007-02-07 Heterocyclische antivirale verbindungen

Country Status (13)

Country Link
US (1) US7531534B2 (de)
EP (1) EP1987027B1 (de)
JP (1) JP2009526808A (de)
KR (1) KR20080094834A (de)
CN (1) CN101384587B (de)
AT (1) ATE491706T1 (de)
AU (1) AU2007216564B2 (de)
BR (1) BRPI0708067A2 (de)
CA (1) CA2642483A1 (de)
DE (1) DE602007011213D1 (de)
ES (1) ES2355945T3 (de)
IL (1) IL193113A0 (de)
WO (1) WO2007093541A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090060872A1 (en) * 2007-08-31 2009-03-05 Idenix Pharmaceuticals, Inc. Phosphadiazine hcv polymerase inhibitors v

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1292310A1 (de) 2000-05-10 2003-03-19 SmithKline Beecham Corporation Neue infektionshemmende mittel
AR036081A1 (es) 2001-06-07 2004-08-11 Smithkline Beecham Corp Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos
WO2003037262A2 (en) * 2001-10-29 2003-05-08 Smithkline Beecham Corporation Novel anit-infectives
WO2003099801A1 (en) * 2002-05-24 2003-12-04 Smithkline Beecham Corporation Novel anti-infectives
US7902203B2 (en) 2002-11-01 2011-03-08 Abbott Laboratories, Inc. Anti-infective agents
US20050075331A1 (en) 2003-10-06 2005-04-07 Pratt John K. Anti-infective agents
US20040097492A1 (en) 2002-11-01 2004-05-20 Pratt John K Anti-infective agents
EP2361913A1 (de) 2002-11-01 2011-08-31 Abbott Laboratories Antiinfektiöse Mittel
US20040162285A1 (en) 2002-11-01 2004-08-19 Pratt John K. Anti-infective agents
WO2004052313A2 (en) 2002-12-11 2004-06-24 Smithkline Beecham Corporation Anti-infectives
AU2003297235A1 (en) 2002-12-17 2004-07-22 Smithkline Beecham Corporation Anti-infectives
WO2006021340A1 (en) * 2004-08-23 2006-03-02 F.Hoffmann-La Roche Ag Heterocyclic antiviral compounds

Also Published As

Publication number Publication date
EP1987027A1 (de) 2008-11-05
CN101384587A (zh) 2009-03-11
IL193113A0 (en) 2009-02-11
CA2642483A1 (en) 2007-08-23
JP2009526808A (ja) 2009-07-23
AU2007216564A1 (en) 2007-08-23
US20080095739A1 (en) 2008-04-24
AU2007216564B2 (en) 2011-09-01
ES2355945T3 (es) 2011-04-01
BRPI0708067A2 (pt) 2011-05-17
EP1987027B1 (de) 2010-12-15
US7531534B2 (en) 2009-05-12
DE602007011213D1 (de) 2011-01-27
KR20080094834A (ko) 2008-10-24
CN101384587B (zh) 2011-03-30
WO2007093541A1 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
MX2012003170A (es) Compuestos heterociclicos antivirales.
MX2010004623A (es) Compuestos heterociclicos antiviricos.
MX2012008443A (es) Nucleosidos antiviricos.
TW200745151A (en) Antiviral nucleosides
WO2009069095A3 (en) Antiviral nucleoside compounds
MX2009008872A (es) Compuestos macrociclicos como inhibidores de proteasa ns3 del virus de hepatitis c.
ATE505475T1 (de) Nukleosidderivate als inhibitoren viraler polymerasen
TW200602064A (en) Nucleoside derivatives for treating hepatitis C virus infection
MX2009004556A (es) Inhibidores de la proteasa ns3 del hcv.
TW200745120A (en) Indolobenzazepine HCV NS5B inhibitors
ATE469155T1 (de) Cyclopropyl-fusionierte indolbenzazepin-hcv-ns5b- hemmer
ATE483712T1 (de) Hcv-ns5b-inhibitoren
MY152070A (en) Macrocyclic quinxaline compounds as hcv ns3 protease inhibitors
CO6190510A2 (es) Inhibidores del virus de la hepatitis c
EA200900676A1 (ru) Ингибиторы вируса гепатита с
TW200720285A (en) Nucleoside compounds for treating viral infections
TW200724540A (en) Heterocyclic antiviral compounds
NO20084637L (no) Cyklopropyl-kondenserte indolobenzaepin HCV NS5B inhibitorer
WO2008051475A3 (en) Hcv ns3 protease inhibitors
MY157435A (en) Heterocyclic antiviral compounds
EA201000948A1 (ru) Ингибиторы вирусной полимеразы
DK2209789T3 (da) Cyclopropyl-kondenserede indolobenzazepin HCV NS5B-hæmmere
MX2012006513A (es) Compuestos heterociclicos antivirales.
MX2011012541A (es) Compuestos heterociclicos antivirales.
MX2011011112A (es) Compuestos antivirales heterociclicos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1987027

Country of ref document: EP